Cargando…

Is there a genetic cause of appetite loss?—an explorative study in 1,853 cancer patients

BACKGROUND: Appetite loss has a major impact on cancer patients. It is exceedingly prevalent, is a prognostic indicator and is associated with inferior quality of life. Cachexia is a multi-factorial syndrome defined by a negative protein and energy balance, driven by a variable combination of reduce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solheim, Tora S., Fayers, Peter M., Fladvad, Torill, Tan, Ben, Skorpen, Frank, Fearon, Kenneth, Baracos, Vickie E., Klepstad, Pål, Strasser, Florian, Kaasa, Stein
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424193/ https://www.ncbi.nlm.nih.gov/pubmed/22535570 http://dx.doi.org/10.1007/s13539-012-0064-8

Ejemplares similares

Is there a genetic cause for cancer cachexia? – a clinical validation study in 1797 patients
por: Solheim, T S, et al.
Publicado: (2011)

P-selectin genotype is associated with the development of cancer cachexia
por: Tan, Benjamin H L, et al.
Publicado: (2012)

Genetic and Non-genetic Factors Associated With Constipation in Cancer Patients Receiving Opioids
por: Laugsand, Eivor A, et al.
Publicado: (2015)

The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis
por: Vagnildhaug, Ola Magne, et al.
Publicado: (2017)

The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer
por: Paulsen, Ørnulf, et al.
Publicado: (2017)

A prospective study examining cachexia predictors in patients with incurable cancer
por: Vagnildhaug, Ola Magne, et al.
Publicado: (2019)

Genetic variation in the Catechol-O-Methyltransferase (COMT) gene and morphine requirements in cancer patients with pain
por: Rakvåg, Trude T, et al.
Publicado: (2008)

Genetic variation and cognitive dysfunction in opioid‐treated patients with cancer
por: Kurita, Geana Paula, et al.
Publicado: (2016)

Health care providers underestimate symptom intensities of cancer patients: A multicenter European study
por: Laugsand, Eivor A, et al.
Publicado: (2010)

A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer
por: Solheim, Tora S., et al.
Publicado: (2017)

New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss
por: Johns, Neil, et al.
Publicado: (2016)

The N-Terminally Truncated µ3 and µ3-Like Opioid Receptors Are Transcribed from a Novel Promoter Upstream of Exon 2 in the Human OPRM1 Gene
por: Andersen, Sonja, et al.
Publicado: (2013)

Can cancer patients assess the influence of pain on functions? A randomised, controlled study of the pain interference items in the Brief Pain Inventory
por: Stenseth, Guri, et al.
Publicado: (2007)

Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer: study protocol for a double-blind, randomized, placebo-controlled, clinical multicenter trial
por: Jakobsen, Gunnhild, et al.
Publicado: (2018)

The short-term impact of methylprednisolone on patient-reported sleep in patients with advanced cancer in a randomized, placebo-controlled, double-blind trial
por: Jakobsen, Gunnhild, et al.
Publicado: (2020)

Inadequate symptom control in advanced cancer patients across Europe
por: Laugsand, Eivor A., et al.
Publicado: (2010)

Trajectory of health-related quality of life during the last year of life in patients with advanced non-small–cell lung cancer
por: Kristensen, Are, et al.
Publicado: (2022)

Arctic Explorations in the Years 1853, '54, '55
Publicado: (1861)

Innate Immune Signalling Genetics of Pain, Cognitive Dysfunction and Sickness Symptoms in Cancer Pain Patients Treated with Transdermal Fentanyl
por: Barratt, Daniel T., et al.
Publicado: (2015)

Power Comparisons and Clinical Meaning of Outcome Measures in Assessing Treatment Effect in Cancer Cachexia: Secondary Analysis From a Randomized Pilot Multimodal Intervention Trial
por: Balstad, Trude R., et al.
Publicado: (2021)

Emergency Palliative Cancer Care: Dexmedetomidine Treatment Experiences—A Retrospective Brief Report on Nine Consecutive Cases
por: Løhre, Erik Torbjørn, et al.
Publicado: (2023)

Structural Basis for the Inhibition of the Autophosphorylation Activity of HK853 by Luteolin
por: Zhou, Yuan, et al.
Publicado: (2019)

Correction to Lancet Rheumatol 2022; 4: e853–63
Publicado: (2023)

Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer—a double-blind, randomized placebo-controlled clinical multicenter phase IV trial
por: Jakobsen, Gunnhild, et al.
Publicado: (2022)

Ansaldo: 1853-1993
por: Ansaldo Spa
Publicado: (1992)

Deterioration in Muscle Mass and Physical Function Differs According to Weight Loss History in Cancer Cachexia
por: Stene, Guro Birgitte, et al.
Publicado: (2019)

Day-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational study
por: Klepstad, Pål, et al.
Publicado: (2004)

Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients
por: Andreassen, Trine Naalsund, et al.
Publicado: (2010)

Pain Intensity Factors Changing Breakthrough Pain Prevalence in Patients with Advanced Cancer: A Secondary Analysis of a Cross-Sectional Observational International Study
por: Løhre, Erik Torbjørn, et al.
Publicado: (2018)

Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients
por: Colombo, Francesca, et al.
Publicado: (2020)

853. Epidemiology of Groups A, C, and G β-Hemolytic Streptococcal Pharyngitis
por: Lim, James Ray Mata, et al.
Publicado: (2019)

Wilhelm Uhthoff (1853–1927)
por: Grzybowski, Andrzej, et al.
Publicado: (2014)

On the Occurrence of Fever at Cowbridge in 1853
por: Camps, William
Publicado: (1856)

1853. Relevance of Actinomyces Bacteremia
por: Sharma, Mamta, et al.
Publicado: (2022)

Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study
por: Andreassen, Trine Naalsund, et al.
Publicado: (2011)

Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors?
por: Currow, David C, et al.
Publicado: (2015)

Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling
por: Pettersen, Kristine, et al.
Publicado: (2017)

Spiritual quality of life in family carers of patients with advanced cancer—a cross-sectional study
por: Røen, Ingebrigt, et al.
Publicado: (2021)

Prediction of opioid dose in cancer pain patients using genetic profiling: not yet an option with support vector machine learning
por: Olesen, Anne Estrup, et al.
Publicado: (2018)

Viajantes por Chihuahua, 1846-1853 /
por: Vargas Valdés, Jesús
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_uh4q32lafvb6pthplfn6eht6vh